3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Phase 3
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
25
Gastrointestinal
12
Gynecologic
7
Plasma cell
2
Lymphoid
2
Genitourinary
1
CNS
1
Conditions
Prostatic Neoplasms
1751
Urinary Bladder Neoplasms
351
Carcinoma, Renal Cell
217
Breast Neoplasms
209
Neoplasms
164
Kidney Neoplasms
157
Lung Neoplasms
101
Colorectal Neoplasms
95
Motor Activity
85
Testicular Neoplasms
59
Ovarian Neoplasms
52
Colonic Neoplasms
48
Melanoma
47
Pancreatic Neoplasms
44
Neoplasm Metastasis
43
Non-Muscle Invasive Bladder Neoplasms
42
Urinary Incontinence
40
Head and Neck Neoplasms
40
Uterine Cervical Neoplasms
39
Carcinoma, Transitional Cell
39
Disease
38
Urologic Neoplasms
36
Sarcoma
36
Recurrence
35
Anxiety Disorders
31
Stomach Neoplasms
29
Carcinoma, Non-Small-Cell Lung
29
Lymphoma
28
Endometrial Neoplasms
28
Prostatic Hyperplasia
27
Interventions
Exercise
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Peripheral Nervous System Diseases
×
Genitourinary
×
Clear all
NCT07548476
2026-05-04
ACE
Dana-Farber Cancer Institute
Phase NA
Not yet recruiting
50 enrolled